AtaiBeckley (ATAI) Interest Expenses (2022 - 2025)
AtaiBeckley (ATAI) posted quarterly Interest Expenses of $59.2 million for Q1 2026, up 6477.22% year-over-year from $900000.0 in Q1 2025, and down 21.56% quarter-over-quarter from $75.5 million in Q4 2025.
Analysis
AtaiBeckley (ATAI) Interest Expenses (2022 - 2025) Analysis & Trends
AtaiBeckley's Interest Expenses history runs 3 years deep, the most recent figure standing at $59.2 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 6477.22% year-over-year to $59.2 million; the TTM figure through Mar 2026 stood at $59.2 million (changed N/A YoY), while the FY2025 annual figure was $147.6 million, up 5.81% from the prior year.
- Interest Expenses for Q1 2026 stood at $59.2 million, down from $75.5 million in the prior quarter.
- Over five years, Interest Expenses peaked at $215.7 million in Q3 2021 and troughed at -$1.7 million in Q4 2024.
- A 5-year average of $25.3 million and a median of $3.4 million in 2024 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2025 and 2026: Interest Expenses surged 1374.23% in 2025, then jumped 6477.22% in 2026.
- AtaiBeckley's Interest Expenses stood at $5.1 million in 2024, then soared by 1374.23% to $75.5 million in 2025, then slipped by 21.56% to $59.2 million in 2026.
- Business Quant data shows ATAI's Interest Expenses at $59.2 million in Q1 2026, $75.5 million in Q4 2025, and $900000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 20.27 Mn |
| 10 | AtaiBeckley | 1.61 Bn | 1.61 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 264,000.00 |
| Jun 30, 2025 | 264,000.00 |
| Mar 31, 2025 | 900,000.00 |
| Mar 31, 2025 | 900,000.00 |
| Dec 31, 2024 | 952,000.00 |
| Sep 30, 2024 | 783,000.00 |
| Jun 30, 2024 | 702,000.00 |
| Mar 31, 2024 | 687,000.00 |
| Dec 31, 2023 | 691,000.00 |
| Sep 30, 2023 | 686,000.00 |
| Jun 30, 2023 | 658,000.00 |
| Mar 31, 2023 | 622,000.00 |
| Dec 31, 2022 | 923,000.00 |